Green tea extract tested to fight frailty in older cancer survivors
NCT ID NCT04553666
First seen May 10, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This pilot study tested whether a green tea extract called EGCG is safe and practical for older cancer survivors who are frail or pre-frail. 24 people aged 65+ who had finished cancer treatment took EGCG or a placebo for 12 weeks. The goal was to see if the supplement could help reduce frailty and inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Rochester
Rochester, New York, 14627, United States
Conditions
Explore the condition pages connected to this study.